Thinking of Investing in PGR? What Our Analysts Know.

By Tamara Parker • Wednesday, June 14 12:21 • Permanent Link

Progressive logged a -3.1% change during today's afternoon session, and is now trading at a price of $127.66 per share. The S&P 500 index moved 0.0%. PGR's trading volume is 1,499,700 compared to the stock's average volume of 2,953,387.

Progressive trades -14.37% away from its average analyst target price of $149.07 per share. The 14 analysts following the stock have set target prices ranging from $123.0 to $198.0, and on average have given Progressive a rating of hold.

Anyone interested in buying PGR should be aware of the facts below:

Progressive's current price is 110.2% above its Graham number of $60.73, which implies that at its current valuation it does not offer a margin of safety
Progressive has moved 17.0% over the last year, and the S&P 500 logged a change of 15.3%
Based on its trailing earnings per share of 1.41, Progressive has a trailing 12 month Price to Earnings (P/E) ratio of 90.5 while the S&P 500 average is 15.97
PGR has a forward P/E ratio of 16.2 based on its forward 12 month price to earnings (EPS) of $7.88 per share
The company has a price to earnings growth (PEG) ratio of 1.0 — a number near or below 1 signifying that Progressive is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 4.56 compared to its sector average of 1.57
The Progressive Corporation, an insurance holding company, provides personal and commercial auto, personal residential and commercial property, general liability, and other specialty property-casualty insurance products and related services in the United States.
Based in Mayfield, the company has 55,100 full time employees and a market cap of $74.72 Billion. Progressive currently returns an annual dividend yield of 0.3%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.